- Home
- CLGN vs CLPS Comparison
CLGN vs CLPS Comparison
Compare CLGN & CLPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- CLPS
- Stock Information
- Founded
- CLGN 2004
- CLPS 2005
- Country
- CLGN Israel
- CLPS Hong Kong
- Employees
- CLGN N/A
- CLPS N/A
- Industry
- CLGN Industrial Specialties
- CLPS Computer Software: Prepackaged Software
- Sector
- CLGN Health Care
- CLPS Technology
- Exchange
- CLGN Nasdaq
- CLPS Nasdaq
- Market Cap
- CLGN 33.8M
- CLPS 27.2M
- IPO Year
- CLGN N/A
- CLPS 2018
- Fundamental
- Price
- CLGN $2.66
- CLPS $1.03
- Analyst Decision
- CLGN Strong Buy
- CLPS
- Analyst Count
- CLGN 2
- CLPS 0
- Target Price
- CLGN $11.50
- CLPS N/A
- AVG Volume (30 Days)
- CLGN 30.5K
- CLPS 10.2K
- Earning Date
- CLGN 08-20-2025
- CLPS 10-17-2025
- Dividend Yield
- CLGN N/A
- CLPS 12.16%
- EPS Growth
- CLGN N/A
- CLPS N/A
- EPS
- CLGN N/A
- CLPS N/A
- Revenue
- CLGN $2,402,000.00
- CLPS $153,816,045.00
- Revenue This Year
- CLGN $1,617.28
- CLPS N/A
- Revenue Next Year
- CLGN $83.54
- CLPS N/A
- P/E Ratio
- CLGN N/A
- CLPS N/A
- Revenue Growth
- CLGN 248.62
- CLPS 5.81
- 52 Week Low
- CLGN $1.31
- CLPS $0.80
- 52 Week High
- CLGN $5.00
- CLPS $1.70
- Technical
- Relative Strength Index (RSI)
- CLGN 52.88
- CLPS 52.92
- Support Level
- CLGN $2.38
- CLPS $0.97
- Resistance Level
- CLGN $2.77
- CLPS $1.07
- Average True Range (ATR)
- CLGN 0.18
- CLPS 0.04
- MACD
- CLGN -0.02
- CLPS -0.00
- Stochastic Oscillator
- CLGN 47.46
- CLPS 52.00
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About CLPS CLPS Incorporation
CLPS Inc is a holding company. The company through its subsidiaries provides information technology consulting and solutions institutions in the banking, insurance, and financial sectors, both in China and globally. Its products are Risk Control Platform, Transaction Acquiring Platform, Debt Collection Platform, Virtual Bank Training Platform, Credit Card System, and other related products. The company generates its revenue from IT consulting services, Customized IT solution services, and others. Generating the majority of its revenue from the IT consulting service.